Associate Professor, Medicine, University of Washington School of Medicine
Hematology
Dr. Paul V. O'Donnell, MD
|
|
Give Review
Paul O'Donnell practices Hematology. He attended Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical college. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine Dr. Paul V. O'Donnell is also published. He has 48 publications published. The lastest publication: "CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis...'
Publications
- European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards.
- Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.
- Anti-CD45 radioimmunotherapy without TBI before BMT facilitates persistent haploidentical donor enGraftment in a murine model.
- Clinical utility of neuronal Cells directly converted from fibroblasts of patients for neuropsychiatric disorders: studies of lysosomal storage diseases and channelopa...
- Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor Cells from unrelated donors, a Center for Inter...
- Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.
- Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies.
- Lower risk of serious adverse events and no increased risk of Cancer after PBSC versus bone marrow donation.
- Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in adv...
- Peripheral blood hematopoietic stem Cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning.
- A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic Cell transplant recipients.
- Alternative transplant donor sources: is there any consensus?
- Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
- A pilot pharmacologic biomarker study of busulfan and fludarabine in hematopoietic Cell transplant recipients.
- Accurate Targeting of Daily Intravenous Busulfan with 8-Hour Blood Sampling in Hospitalized Adult Hematopoietic Cell Transplant Recipients.
- Alternative donor transplantation: results of parallel phase II trials using HLA-mismatched related bone marrow or unrelated umbilical cord blood Grafts.
- Pharmacogenetics of Intravenous and Oral Busulfan in Hematopoietic Cell Transplant Recipients.
- Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.
- Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.
- A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic Cell transplant patients.
- The contribution of malglycemia to mortality among allogeneic hematopoietic Cell transplant recipients.
- Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic Cell transplantation following nonmyeloablative conditioning for ...
- HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.
- Reduced incidence of Acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
- Long-term follow-up of T Cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T Cells.
- Nonmyeloablative alternative donor transplants.
- Interaction between Epstein-Barr virus and a T Cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.
- The magnetic resonance imaging appearances of the brain in Acute carbon monoxide poisoning.
- WW domains provide a platform for the assembly of multiprotein networks.
- Nonbacterial osteitis: a clinical, histopathological, and imaging study with a proposal for protocol-based management of patients with this diagnosis.
- The prevalence and diagnostic significance of fluid-fluid levels in focal lesions of bone.
- Brachyury expression in extra-axial skeletal and soft tissue Chordomas: a marker that distinguishes Chordoma from mixed tumor/myoepithelioma/paraChordoma in soft tissue.
- D(1) dopamine receptors potentiate nmda-mediated excitability increase in layer V prefrontal cortical pyramidal neurons.
- A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone.
- Using point-of-care CD34 enumeration to optimize PBSC collection conditions.
- Systemic interleukin-2 and adoptive transfer of lymphokine-activated killer Cells improves antibody-dependent Cellular cytotoxicity in patients with relapsed B-Cell ly...
- Long-term results of blood and marrow transplantation for Hodgkin's Lymphoma.
- CD34+ stem Cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis...
- Histology and Time to Progression Predict Survival for Lymphoma Recurring after Reduced-Intensity Conditioning and Allogeneic Hematopoietic Cell Transplantation.
- Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with Acute myeloid leukemia in first remission.
- CD34 selection using three immunoselection devices: comparison of T-Cell depleted allografts.
- Immunotherapy with rituximab during peripheral blood stem Cell transplantation for non-Hodgkin's lymphoma.
- Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide.
- Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for Acute myeloid leukaemia beyond first remission: a 10-year experience.
- Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic Cell transplantation centers in the United States.
- Myeloablative allogeneic bone marrow transplant using T Cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes.
- A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic Cell transplantation patients.
Schools
Johns Hopkins University School of Medicine
Johns Hopkins Hospital
Johns Hopkins Onc Center
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Basal Cell Carcinoma
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Choice Health
- First Health (Coventry Health Care) PPO
- Group Health Cooperative
- Choice Care PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- ODS Health Plan
- Providence Health Plans
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Johns Hopkins University -
Johns Hopkins University School of Medicine
Hospital
-
UW Medicine/Harborview Medical Center -
University of Washington Medical Center -
Massachusetts General Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1548359698 |
| Last Name Of The Provider | O'DONNELL |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Peter S. Nelson, MD |
|
|
Dr. Georgiana K. Ellis, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Milder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jerald P. Radich, MD |
|
Dr. Thomas W. Malpass, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl A. Blau, MD |
|
|
Dr. Jose A. Lopez, MD |
|
|
Dr. Raya Mawad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew R. Rezvani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zachary F. Zimmerman, MD |
|
|
Dr. Konstantinos G. Balotis, MD |
|
|
Dr. Daniel N. Egan, MD |
|
|
Dr. Aude Chapuis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William E. Hobbs II, MD |
|
|
Dr. Melinda A. Biernacki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yoshihiro Inamoto, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Romeo A. De Claro, MD |
|
|
Dr. Niranjan N. Rathod, MD |
|
|
Dr. Andrew S. Sandler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Akshay D. Shah, MD |